BIND Biosciences Raises Venture Capital Debt


	Subscribe \| Contact Us \|

Friday, October 14, 2011 5:32:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts -- Biotechnology company BIND Biosciences has secured $4.75 million in new venture capital debt financing, according to an SEC regulatory filing.

BIND has created a nanoengineering platform that develops therapeutic targeted nanoparticles.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page | Print Page

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.